Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group 1 | Other | Test Drug for Period I Reference Drug for Period II |
|
| Group 2 | Other | Reference Drug for Period I Test Drug for Period II |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Test Drug(JW0302) or Reference Drug(C2206) | Drug | Test Drug: single administration of JW0302 Reference Drug: single administration of C2206 Tablet, Oral, QD for 1 Days, Washout period is more than 14 days after administration |
| Measure | Description | Time Frame |
|---|---|---|
| AUCÏ„, SS(Area under the plasma drug concentration-time curve within a dosing interval at steady state) | Evaluation PK for JW0302 and C2206 after multiple dose | up to 24 hours |
| Percent decrease from baseline in integrated gastric acidity for 24-hour interval after 7th dose | Evaluation PD for ambulatory 24hr pH monitor | Baseline versus Multiple dose during 7 days |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| SeungHwan Lee, PI | Clinical Trial Center, Seoul National University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Clinical Trial Center, Seoul National University Hospital | Seoul | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A randomized, open, single-dose, 2x2 crossover-design clinical trial
Not provided
Not provided
Not provided
Not provided